FDA Discontinues Risk Evaluation and Mitigation Strategy (REMS) for Clozapine, an Antipsychotic Medication

FDA Discontinues Risk Evaluation and Mitigation Strategy (REMS) for Clozapine, an Antipsychotic Medication

FDA Discontinues Risk Evaluation and Mitigation Strategy (REMS) for Clozapine, an Antipsychotic Medication